CHRISTY OVERSTREET: Open Payments
NPI 1164838975 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 32 payments from 10 companies in 2025. Trend: 2023 $1,022 · 2024 $977 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $163 |
| Novo Nordisk Inc | 3 | $55 |
| PFIZER INC. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Insulet Corporation | 2 | $37 |
| Lilly USA, LLC | 2 | $29 |
| Verona Pharma, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: UBRELVY, VRAYLAR, QULIPTA, Ozempic, Omnipod, PREVNAR 20, MOUNJARO, Ohtuvayre.
Industry payments across KY — which companies pay providers there.
